SCHEMBL3023740

SCHEMBL3023740

CC(C)CN(O)C(=O)c1cccc(-c2ccc(C(N)=O)cc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 4/20 0.47
AOC3 Q16853 2/20 0.46
CTSS P25774 1/20 0.45
CTSK P43235 1/20 0.45
LMNA P02545 1/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
ADAMTS4 O75173 1/20 0.43
DHODH Q02127 2/20 0.42
HPGDS O60760 1/20 0.42
TRPV1 Q8NER1 2/20 0.42
MGLL Q99685 1/20 0.42
CSF1R P07333 1/20 0.41
FLT1 P17948 1/20 0.41
FLT3 P36888 1/20 0.41
GABRA1 P14867 1/20 0.41
GABRB2 P47870 1/20 0.41
HSD17B1 P14061 1/20 0.41
HSD17B2 P37059 1/20 0.41
MKNK1 Q9BUB5 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3453878 0.79 LCK (0.47) RORC
SCHEMBL2589651 0.76 ERN1 (0.60) TSHRDHODHCSF1RFLT1FLT3
SCHEMBL3025997 0.76 HPGD (0.58) AOC3LMNAHPGDTSHRHSD17B2
SCHEMBL3025882 0.75 HSD17B2 (0.61) AOC3LMNAHPGDTSHRHSD17B1
SCHEMBL6273049 0.75 GAA (0.66) CTSSCTSKHPGDADAMTS4HPGDS
SCHEMBL3453782 0.73 AOC3 (0.44) RORCAOC3HSD17B1HSD17B2
SCHEMBL3037021 0.73 MKNK1 (0.54) AOC3HSD17B1HSD17B2MKNK1MKNK2
SCHEMBL3037268 0.73 HSD17B2 (0.54) AOC3LMNAHPGDTSHRHSD17B2
SCHEMBL3034655 0.72 MAOB (0.52) AOC3DHODHHSD17B1HSD17B2
SCHEMBL3036418 0.72 PARP1 (0.50) DHODHCSF1RFLT1FLT3HSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS KATTAR SOLOMON 2010-08-26 US claimed
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS KATTAR SOLOMON 2010-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS BRDT, AADAC, ACIN1 RORC 1386/4885AOC3 1923/4885CTSS 2213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.